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examine which drugs had generic equivalents available for each
year. The Pharmaceutical Red Book was referred for drug pricing
and product information. RESULTS: Generic drugs accounted
for almost half of total prescription drugs dispensed in 2003 as
compared to 19% in 1983. In 1990, two of the ten drugs pre-
scribed in outpatient clinics were generics, which rose to six in
2003. Out of ten top-selling drugs, six drugs will lose their
patents in next ﬁve years. In 1990, none of the top ten derma-
tological drugs were generics. With few drugs losing their patents
since 1990 (e.g. Retin-A®), two out of top ten dermatological
drugs were generics in 2003. CONCLUSIONS: This study ﬁnds
an increasing trend in the availability of generic medications.
However, concerns regarding the bioavailability of generic equiv-
alents used in dermatological conditions may limit their use.
However, increased pressure from managed care organizations
to prescribe inexpensive generics, overall growth in generic drug
market, and anticipated drug patent expirations may inﬂuence
prescribing patterns of these medications.
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OBJECTIVE: To investigate the relationship between health
status, costs linked with the treatment of acne in the United
States and aspects related to medication use. METHODS: The
United States Medical Expenditure Panel Survey (MEPS) data-
base was analyzed for a cohort of people with acne. Patients for
this study were identiﬁed using the ICD-9 (International Classi-
ﬁcation of Diseases, 9th revision) code “706” for acne vulgaris
and similar conditions (The MEPS dataset uses only the ﬁrst
three digits of the ICD-9 codes to identify disease states). Records
of medical events were obtained using this ICD-9 code for acne
and the receipt of medication for acne. This cross sectional study
obtained costs, demographics, health care service utilization and
clinical patient variables from the MEPS database. The subjects
were divided into categories depending on type of medications
used, mainly, oral antibiotics, oral retinoids, oral contraceptives,
topical antibiotics, topical retinoids and oral contraceptives. The
EuroQOL (EQ-5D) scores available in MEPS for subjects 18
years and older were used for obtaining health status informa-
tion for these patients. Indices for medication adherence and
comorbidities were also calculated using the data from the
MEPS. Multivariate weighted analysis was performed on data
for approximately 5 million patients (weighted sample size).
RESULTS: Nearly 70% of the patients used some type of med-
ication for acne. Acne-related medication accounted for approx-
imately 36% of the total acne related health care costs, with an
average of 2 annual acne prescription reﬁlls. Increased number
of reﬁlls of acne speciﬁc drugs was associated with an improve-
ment in health status (p < 0.05). Increased ofﬁce based visits were
the only predictors of higher acne related health care costs (p <
0.01). CONCLUSIONS: Adherence to acne medications is an
important component of better health status. Pharmacological
treatment of acne does not signiﬁcantly add to acne-related
health care costs.
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OBJECTIVES: To validate a scale for functional discomfort due
to nail psoriasis. The questionnaire will have to be adapted both
in the case of toe or ﬁnger nail psoriasis. The measured criterion
will be unidimensional and related to the bother caused by nail
psoriasis in daily life. METHODS: The scale was developed
according to the international recommendations on quality of
life. In October 2004, a questionnaire was sent to 4000
members, selected by drawing lots, among the French patients
support group (APLCP). The ﬁrst step of the process has led to
the selection of 10 items related to functional discomfort induced
by nail psoriasis. RESULTS: In total, 795 questionnaires con-
cerning individuals affected by nail psoriasis were analysed. Val-
idation analyses included the 10 selected items. Questionnaire’s
contents were coherent with the a-Cronbach coefﬁcient equaling
0.88. The unidimensional feature of the questionnaire was veri-
ﬁed: the analysis in principal components revealed that 49% of
the total variance was explained by one component. The DLQI
speciﬁc to dermatological pathologies was also given and
enabled a comparison with the scale. Pearson’s correlation coef-
ﬁcient between both scales was 0.48. The severity of the affec-
tion assessed through the DLQI evolved in the same way as the
evaluation for the “Nail Psoriasis” scale. A test-retest performed
on a sample of 15 individuals showed that the scale could be
reproduced with an intra-class correlation coefﬁcient of 0.82
between 2 administrations. CONCLUSION: The “Nail Psoria-
sis” scale is simple to use and easy to give to the patient. The
qualitative features which must be found in a quality of life scale
have been checked: comprehensibility, reliability and validity.
The scale will have to be used during clinical trials in order to
demonstrate its ability in measuring change in condition (before
and after treatment).
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Quality of life instruments are increasingly important in assess-
ing disease severity. However, some of these measurements have
been developed on a more or less ad hoc basis. Although not
well standardised, psychometric analyses can be used to re-test,
reﬁne and shorten existing quality of life instruments more
strictly. OBJECTIVES: To psychometrically test and reﬁne the
Impact of Psoriasis Questionnaire (IPSO) and to compare the
results of two different statistical approaches. METHODS:
Among 792 psoriasis patients who were included in the PUVA
Follow Up Study, we used Classical Test Theory (CTT) and
Rasch analysis to test and optimise the IPSO. Thereafter, two
shortened versions of the IPSO derived from these models were
compared. RESULTS: CTT analyses of the original IPSO demon-
strated suboptimal item performance for 6 of 16 items and inap-
propriate subscaling. In contrast to the original 4 subscales,
factor analysis of the CTT version yielded 3 subscales (mental
functioning, mental wellbeing and stigmatisation). The Rasch
approach, which included ordering of thresholds, differential
item functioning and item ﬁt, resulted in an unidimensional 11-
